CASE
STUDY ABSTRACT, OBJECTIVES & DESIGN |
CASE A Multi-Method Approach to Measuring Antiretroviral Therapy (ART) Adherence from the Cross-Site New York Academy of Medicine Center for Adherence Support Evaluation /HRSA SPNS Adherence Collaboration Background: High rates of adherence to ART is critical to success with treatment. However, the optimal measure of adherence in clinical practice is still unknown. Methods: As part of the New York Academy of Medicine/ HRSA initiative, we are evaluating the impact of 13 adherence support programs. Adherence was measured using 3-day self-report, last time missed and number of days/week with a missed dose. Baseline adherence data from the 312 patients from 8 of the 13 sites on ART at enrollment were used in these analyses to evaluate the relationship among different adherence measures. Data were collected through face-to-face interviews using a standardized adherence questionnaire. Results: The sample was 39% female, 68% minority; 47% reported mental illness and 16% active drug use. Only 29% had a viral load <400 at baseline. Nonadherence (>1 dose missed) by 3-day recall correlated with frequency
of days/week with a missed dose (p=.001), difficulty taking medications
on time (p=.001), and last time missed dose (p=.001). Presence and number
of side effects predicted adherence (p=.001).
Conclusions: Correlations between a number
of self-report adherence measures were found in this diverse multi-site
population. As more data are collected, we will be able to develop a composite
adherence measure to improve accuracy of adherence assessment in the field.
CASE The New York Academy of Medicine 1216 Fifth Avenue New York, NY 10029 (212) 822-7237 Last updated: 4/11/02 |